Amgen
This lab-based role supports the design, development, validation, and implementation of robust LC–MS/MS bioanalytical methods for various therapeutic modalities, including small molecules, oligonucleotides, and proteins. The position focuses on expanding discovery-stage support while maintaining flexibility for GLP preclinical and regulated clinical activities. The role involves contributing to the modernization of automation and instrumentation to improve assay throughput and sensitivity.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
44% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago